PL3426230T3 - Stałe postacie dawkowania wigabatryny - Google Patents
Stałe postacie dawkowania wigabatrynyInfo
- Publication number
- PL3426230T3 PL3426230T3 PL16716674.3T PL16716674T PL3426230T3 PL 3426230 T3 PL3426230 T3 PL 3426230T3 PL 16716674 T PL16716674 T PL 16716674T PL 3426230 T3 PL3426230 T3 PL 3426230T3
- Authority
- PL
- Poland
- Prior art keywords
- vigabatrin
- dosage forms
- solid dosage
- solid
- forms
- Prior art date
Links
- 239000007909 solid dosage form Substances 0.000 title 1
- PJDFLNIOAUIZSL-UHFFFAOYSA-N vigabatrin Chemical compound C=CC(N)CCC(O)=O PJDFLNIOAUIZSL-UHFFFAOYSA-N 0.000 title 1
- 229960005318 vigabatrin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2016/000436 WO2017153800A1 (en) | 2016-03-10 | 2016-03-10 | Solid dosage forms of vigabatrin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3426230T3 true PL3426230T3 (pl) | 2024-11-04 |
Family
ID=55754334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16716674.3T PL3426230T3 (pl) | 2016-03-10 | 2016-03-10 | Stałe postacie dawkowania wigabatryny |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10813898B2 (pl) |
| EP (1) | EP3426230B1 (pl) |
| CA (1) | CA3016851A1 (pl) |
| ES (1) | ES2985625T3 (pl) |
| PL (1) | PL3426230T3 (pl) |
| WO (1) | WO2017153800A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10813898B2 (en) | 2016-03-10 | 2020-10-27 | Orphelia Pharma | Solid dosage forms of vigabatrin |
| GB2591389A (en) | 2018-08-18 | 2021-07-28 | Ftf Pharma Private Ltd | Pharmaceuticals solution for oral dosage |
| CN116120200B (zh) * | 2021-11-15 | 2025-08-29 | 武汉武药科技有限公司 | 氨己烯酸原料药、氨己烯酸固体组合物及其制备方法 |
| CN115227658B (zh) * | 2022-04-25 | 2023-09-22 | 上海奥科达医药科技股份有限公司 | 一种氨己烯酸固体制剂组合物 |
| WO2024058812A1 (en) | 2022-09-16 | 2024-03-21 | Pyros Pharmaceuticals, Inc. | Vigabatrin liquid pharmaceutical composition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5784499A (en) * | 1998-08-25 | 2000-03-14 | Sepracor, Inc. | Methods and compositions employing optically pure s(+) vigabatrin |
| CA2566362C (en) * | 2004-05-15 | 2013-09-10 | Vertex Pharmaceuticals Incorporated | Treating seizures using ice inhibitors |
| EP1927348A1 (en) * | 2006-11-22 | 2008-06-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Anticonvulsive pharmaceutical compositions |
| US20130078290A1 (en) * | 2010-06-01 | 2013-03-28 | Rubicon Research Private Limited | Gastroretentive Dosage Forms Of GABA Analogs |
| WO2012029838A1 (ja) * | 2010-08-31 | 2012-03-08 | 協和発酵キリン株式会社 | 口腔内崩壊錠 |
| US10813898B2 (en) | 2016-03-10 | 2020-10-27 | Orphelia Pharma | Solid dosage forms of vigabatrin |
-
2016
- 2016-03-10 US US16/081,926 patent/US10813898B2/en active Active
- 2016-03-10 CA CA3016851A patent/CA3016851A1/en not_active Abandoned
- 2016-03-10 EP EP16716674.3A patent/EP3426230B1/en active Active
- 2016-03-10 ES ES16716674T patent/ES2985625T3/es active Active
- 2016-03-10 PL PL16716674.3T patent/PL3426230T3/pl unknown
- 2016-03-10 WO PCT/IB2016/000436 patent/WO2017153800A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20190070138A1 (en) | 2019-03-07 |
| EP3426230A1 (en) | 2019-01-16 |
| EP3426230B1 (en) | 2024-08-07 |
| WO2017153800A1 (en) | 2017-09-14 |
| US10813898B2 (en) | 2020-10-27 |
| ES2985625T3 (es) | 2024-11-06 |
| CA3016851A1 (en) | 2017-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287437A (en) | Flavociclib solid dosage forms | |
| NO2023005I1 (no) | tirzepatide | |
| IL263586B (en) | Inhibitors of the menin-mll interaction | |
| PL3131533T3 (pl) | Doustna postać dawkowania ketaminy | |
| SI3529248T1 (sl) | Farmacevtske spojine | |
| DK3244948T3 (da) | Bestemmelse af medikamentdosis | |
| DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
| HUE054467T2 (hu) | Lipofil vegyületek szilárd orális adagolási formája | |
| SI3936130T1 (sl) | Režim odmerjanja valbenazina za zdravljenje hiperkinetičnih gibalnih motenj | |
| DK3102213T3 (da) | Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser | |
| DK3511319T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| KR102254062B9 (ko) | 삼나트륨 발사르탄:사쿠비트릴의 고체 형태 | |
| LT3116491T (lt) | Terapiškai aktyvių junginių farmacinės kompozicijos | |
| DK3529240T3 (da) | Farmaceutiske forbindelser | |
| DK3132009T3 (da) | Fremgangsmåde | |
| DK3283210T3 (da) | Fremgangsmåde | |
| HRP20181570T1 (hr) | Režim doziranja spoja fgf-18 | |
| LT3212237T (lt) | Metotreksato vaistinė forma | |
| DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
| IL254502A0 (en) | Solid forms of menaquinols | |
| DK3215223T3 (da) | Buprenorphindoseringsskemaer | |
| HUE050890T2 (hu) | Nilotinib sók szilárd halmazállapotú formái | |
| PL3417294T3 (pl) | Sposoby obejmujące stałe, przerywane dawkowanie cedyranibu | |
| IL269169A (en) | Novel dosage form | |
| DK3288967T3 (da) | Farmaceutisk forbindelse |